Publications powered by Harvard Catalyst Profiles

1. The Surgical Program in Innovation (SPIN): A Design and Prototyping Curriculum for Surgical Trainees. Acad Med. 2021 Feb 02. View abstract
2. Optimizing Duration of Empiric Management of Suspected Central Line-Associated Bloodstream Infections in Pediatric Patients with Intestinal Failure. J Pediatr. 2020 12; 227:69-76.e3. View abstract
3. Alpha-tocopherol in intravenous lipid emulsions imparts hepatic protection in a murine model of hepatosteatosis induced by the enteral administration of a parenteral nutrition solution. PLoS One. 2019; 14(7):e0217155. View abstract
4. Omega-3 fatty acids are protective in hepatic ischemia reperfusion injury in the absence of GPR120 signaling. J Pediatr Surg. 2019 Nov; 54(11):2392-2397. View abstract
5. Fish oil protects the liver from parenteral nutrition-induced injury via GPR120-mediated PPAR? signaling. Prostaglandins Leukot Essent Fatty Acids. 2019 04; 143:8-14. View abstract
6. A Diet With Docosahexaenoic and Arachidonic Acids as the Sole Source of Polyunsaturated Fatty Acids Is Sufficient to Support Visual, Cognitive, Motor, and Social Development in Mice. Front Neurosci. 2019; 13:72. View abstract
7. Vascular Endothelial Growth Factor Enhances Compensatory Lung Growth in Piglets. Surgery. 2018 12; 164(6):1279-1286. View abstract
8. Effects of dietary omega-3 fatty acids on bones of healthy mice. Clin Nutr. 2019 10; 38(5):2145-2154. View abstract
9. Vascular endothelial growth factor accelerates compensatory lung growth by increasing the alveolar units. Pediatr Res. 2018 06; 83(6):1182-1189. View abstract
10. Pretreatment with intravenous fish oil reduces hepatic ischemia reperfusion injury in a murine model. Surgery. 2018 05; 163(5):1035-1039. View abstract
11. Parenteral Soybean Oil Induces Hepatosteatosis Despite Addition of Fish Oil in a Mouse Model of Intestinal Failure-Associated Liver Disease. JPEN J Parenter Enteral Nutr. 2018 02; 42(2):403-411. View abstract
12. Technique and perioperative management of left pneumonectomy in neonatal piglets. J Surg Res. 2017 05 15; 212:146-152. View abstract
13. Methods to Reduce Medication Errors in a Clinical Trial of an Investigational Parenteral Medication. Contemp Clin Trials Commun. 2016 Dec 15; 4:64-67. View abstract
14. Risk of post-procedural bleeding in children on intravenous fish oil. Am J Surg. 2017 Oct; 214(4):733-737. View abstract
15. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children. Am J Clin Nutr. 2016 09; 104(3):663-70. View abstract
16. A Comparison of Fish Oil Sources for Parenteral Lipid Emulsions in a Murine Model. JPEN J Parenter Enteral Nutr. 2017 02; 41(2):181-187. View abstract
17. Eucaloric Ketogenic Diet Reduces Hypoglycemia and Inflammation in Mice with Endotoxemia. Lipids. 2016 06; 51(6):703-14. View abstract
18. Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease [Formula: see text]. JPEN J Parenter Enteral Nutr. 2017 08; 41(6):930-937. View abstract
19. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am J Clin Nutr. 2016 Feb; 103(2):629S-34S. View abstract
20. Intravenous Lipid Emulsions in Parenteral Nutrition. Adv Nutr. 2015 Sep; 6(5):600-10. View abstract
21. Clinically Relevant Mechanisms of Lipid Synthesis, Transport, and Storage. JPEN J Parenter Enteral Nutr. 2015 Sep; 39(1 Suppl):8S-17S. View abstract
22. Challenging the 48-Hour Rule-Out for Central Line-Associated Bloodstream Infections in the Pediatric Intestinal Failure Population: A Retrospective Pilot Study. JPEN J Parenter Enteral Nutr. 2016 05; 40(4):567-73. View abstract
23. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy. Ann Surg. 2015 Jan; 261(1):172-9. View abstract
24. The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice. Metabolism. 2015 Feb; 64(2):274-82. View abstract
25. Elevated Alkaline Phosphatase in Infants With Parenteral Nutrition-Associated Liver Disease Reflects Bone Rather Than Liver Disease. JPEN J Parenter Enteral Nutr. 2015 Nov; 39(8):973-6. View abstract
26. Surgical therapies for fecal incontinence. Curr Opin Gastroenterol. 2014 Jan; 30(1):69-74. View abstract
27. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions. Adv Nutr. 2013 Nov; 4(6):711-7. View abstract
28. Neonatal intestinal physiology and failure. Semin Pediatr Surg. 2013 Nov; 22(4):190-4. View abstract
29. Role of parenteral lipid emulsions in the preterm infant. Early Hum Dev. 2013 Oct; 89 Suppl 2:S45-9. View abstract
30. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease. Prostaglandins Leukot Essent Fatty Acids. 2013 Sep; 89(4):153-8. View abstract
31. Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease. Curr Opin Pediatr. 2013 Apr; 25(2):193-200. View abstract
32. Prosthetic graft infections involving the femoral artery. J Vasc Surg. 2013 Mar; 57(3):700-5. View abstract
33. The impact of endovascular procedures on fellowship training in lower extremity revascularization. J Vasc Surg. 2012 Jun; 55(6):1814-20. View abstract
34. Advances in the surgical management of inflammatory bowel disease. Curr Opin Gastroenterol. 2012 Jan; 28(1):47-51. View abstract
35. Stroke of the posterior cerebral circulation. Int Angiol. 2011 Apr; 30(2):105-14. View abstract
36. Laser-induced endothelial cell activation supports fibrin formation. Blood. 2010 Nov 25; 116(22):4675-83. View abstract
37. Prevalence and impact of the subclavian steal syndrome. Ann Surg. 2010 Jul; 252(1):166-70. View abstract